7589
For the serotype-specific factors, we used estimates of reported cases per 1000 7590 infections (medians for fixed-duration cross-protection in Table 2 of supplement in [2] ), 7591 and the observed proportions of mild and severe disease by serotype (Table 4 of [3] , 7592 using all-years; DF versus sum of all DHF and deaths). For serotype i, the reported 7593 cases, C i , relate to the pathogenicity, ρ i , the mild fraction, f i , and the mild and severe 7594 expansion factors, EF m and EF s by
Using these values, we calculated the relative-risk compared to infection by DENV1, 7596 ρi ρ1 , based on the sample parameter values for the expansion factors and values of 7597 (C i , f i ) from the literature; see A.
7598
For previous exposure factors, we divide infections into primary infections (no 7599 previous dengue exposure), secondary infections, and post-secondary infections. For 7600 secondary infections, pathogenicity is a fitted parameter. For post-secondary infections, 7601 the relative-risk of pathogenicity is fixed at 0.1. Primary infections, however, depend on 7602 age.
7603
For primary infections, newborns (age 0 individuals) may have maternal antibodies. 7604 Whenever newborns are exposed to an infectious bite, we randomly draw an individual 7605 Table A . The estimated number of reported cases per 1000 infections, C i [2] , and observed proportion of mild disease, f i [3] , by serotype.
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from the females in their household of child-bearing age (15-45 years old) to identify a 7606 "mother". If that mother has a past dengue infection, then the infant may have maternal 7607 antibodies and we draw an age in months for the infant uniformly between 0 and 11.
7608
We treat maternal antibodies as cross-immunizing in months 0-2, disease-enhancing
7609
(i.e., like a second infection) in months 3-8, and as having no effect at 9+ months. For 7610 all other ages, we use a step-wise approximation of the curve from [4] for pathogenicity 7611 relative-risk. In our model, age is only a factor for pathogenicity of primary infections, 7612 in contrast to the model described in [5] .
7613
To determine case severity, we fit a parameter for the probability of severe (i.e.
7614
DHF, DSS, or death) disease in secondary cases, fit relative-risk of primary cases
7615
(compared to secondary cases) that is constrained to be less than 1, and assume a fixed 7616 relative-risk (to secondary cases) of 0.2 for post-secondary cases.
7617

S1.4: Dengue Introductions
Empirically and in the model, local dengue 7618 transmission generally ceases during the winter and spring, which is relatively dry and 7619 cool (Fig. A, panel D) . It is possible for transmission chains to persist, but improbable 7620 because R 0 < 1 from late fall to early spring. To continue to have outbreaks in our 7621 model, we re-introduce dengue from an unmodeled external source (representing, e.g., 7622 travelers that import it from a distinct human population, zoonotic introductions),
7623
similar to what may happen in the real system. This external source may also present 7624 novel serotypes to the population. We model these introductions as random exposures 7625 in the human population, and they may be resisted if an individual is vaccinated or has 7626 been previously infected.
7627
The daily number of people exposed is sampled based on a fitted parameter, λ E : # 7628 exposed per circulating serotype ∼ Pois(λ E ) (see Section S5). This rate is flat over time: 7629 it does not vary by year, nor seasonally over the course of a year. However, since it is 7630 the rate per circulating serotype, the total introduction rate is higher in years with more 7631 circulating serotypes. When an exposure occurs, it is randomly assigned one of the Table B) 7636 indicates that serotypes are present (runs) and then absent (gaps) in streaks [6] . Before 7637 each simulation begins, time series are independently constructed for each of the four 7638 serotypes. For the fitting period, we introduce the serotypes in the years in which they 7639 were observed. For historical periods with no recorded data and the forecast period, 7640 time series are generated for each of the four serotypes according to separately fit 7641 geometric distributions (see Section S5). In a given year there may be any combination 7642 of serotypes 1-4 introduced, including no serotypes. Fig. 4 ) [7, 8] . In that study, serum samples were collected from a random 7646 sample of the population aged from one month to 65 years old who lived in Mérida, 7647 with a particular focus on children (aged 2-10). The adults were sampled from 7648 healthcare facilities in the study area and children were sampled from the general 7649 population and schools.
7643
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7650
The age-group-specific prevalence of pre-existing antibody-mediated immunity to 7651 any of the dengue viruses was defined as the proportion of the sampled individuals in 7652 the age group whose serologic specimen is positive to any serotype using Panbio Dengue 7653 IgG Indirect ELISA (titer > 0.10). We computed the exact binomial confidence 7654 intervals (95%) for these prevalence estimates. International (IPUMS) data [10] . IPUMS characterizes households by number of 7673 residents, their ages, genders, and employment/student status. Individual households 7674 were sampled from the IPUMS household distribution for each municipality.
7655
S2 Synthetic Humans
7675
Using boundaries from DIVA-GIS [11] , households are located by pixel (resolution of 7676 ∼500m) within each municipality, proportional to light output recorded by nighttime 7677 satellite imagery [12] (main text, Fig. 1 People are assigned to daytime locations according to the rules below. Rules are 7697 listed in order of precedence.
7698
Everyone with an employment status code that is a student code goes to a school. 7699 Everyone with an employment status code that is a work code goes to a workplace. 7700
Children under 5 years stay home.
7701
Children age 5-11 years go to school. using a censored gravity model: the donor was selected from the closest 100 individuals 7732 that were one year younger, with probability proportional to the inverse squared 7733 distance between recipient and donor. However, this approach produced no apparent 7734 difference in dynamics and was substantially more computationally demanding.
7702
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Newborns (age 0 individuals) have no prior exposure, but may have maternal antibodies 7736 present (see next section for details) contributed from a female in their household.
7737
We "age" the entire population on day 99 of the Julian calendar, which corresponds 7738 to April 9 of non-leap years. This is approximately the middle of the inter-epidemic [16] . We define the work/school day as 9 to 5, thus there is a 24% preference for 7754 dusk-night-dawn biting, and 76% for daytime biting.
7755
For each location, we calculate the biting-time-preference weighted total human 7756 population, n, and the preference weighted infectious human population, v, from the 7757 biting preference and time-dependent human populations. From n and v, we calculated 7758 the weighted fraction of bites that expose mosquitoes to infection, f v :
We use f v with the effective biting rate, β HM , to determine to determine the number 7760 of newly infected mosquitoes: was the location's capacity minus the number of infected mosquitoes generated at that 7766 location that are still alive [5] . The infecting serotype is drawn from the serotype 7767 frequencies at that location, also time-weighted by biting preference.
7768
Infected mosquitoes are represented as mobile, individual agents that are generated 7769 in locations with infected humans. Infectious mosquitoes make an infectious bite (which 7770 may be resisted via immunity) with probability β MH each day; this parameter 7771 represents the product of biting frequency and mosquito-to-human transmissibility, and 7772 β MH can be understood as the daily probability of transmission per infectious mosquito 7773 in a fully susceptible human population. Infectious bites occur either during the day or 7774 night, proportional to the population during those times weighted by biting preference: 7775
Once bite timing is drawn, the bitten individual is randomly drawn from those order to make all years have exactly 365 days.
7782
EIP, or time between a mosquito taking up virus from a host until the mosquito is 7783 able to transmit the virus, is highly sensitive to ambient temperature [1] . Chan and 7784 Johansson (2012) found that the distribution of EIP (in days) for dengue at a constant 7785 temperature (in Celsius) is best fit by a Log-Normal (ln N ) distribution:
However, the real environment has a seasonally varying temperature, not a constant 7787 one, so we must integrate to obtain the correct expected EIP as a function of time of 7788 year. We can do so by calculating the incubation rate associated with the expected EIP 7789 (EIP = e
2 ) in a given interval δt i with temperature T i :
Then the EIP forward from time interval k is
We used an input time series of hourly (i.e. ∆t i = 1/24) temperatures for Mérida, 7792 and linearly pro-rated the final interval to obtain EIP k = 1 exactly. This time series
7793
was not complete for the fitting interval (missing ∼8.6% of hourly temperature 7794 readings), so we estimated missing values using temperature data from Miami, USA,
7795
which is climatically similar to Mérida and is more complete (∼0.02% missing). We 7796 related the temperatures between Miami and Mérida using ordinary least squares 7797 regression, which in turn identified high standardized residual (|SR| > 5) in a modest 7798 number (73 out ∼334k non-missing points, or 0.02%) of points in the Mérida time series. 7799 We discarded these points, refit, and used the resulting model to fill in missing 7800 temperatures. We used the hourly temperatures to calculate hourly incubation rates, 7801 which we then integrated over as described above to obtain the EIPs on an hourly basis. 7802 We found the weighted average EIP for each day using the day versus night biting 7803 preferences assumptions (see previous section). In the simulation, this expected EIP is 7804 used to calculate µ for the Log-Normal distribution on a particular day, which we draw 7805 from when infecting mosquitoes.
7806
Mosquito population size also varies seasonally. The number of susceptible 7807 mosquitoes per location is dependent on a daily scaling factor, and a location-specific 7808 baseline capacity.
7809
Daily scaling factors are based on precipitation history (Fig. A, panel B ) in Mérida. 7810 Using a climatological dataset from NOAA, we calculated the proportion of years that 7811 each day had precipitation. We then fit a cubic smoothing spline, lagged by 7 days to 7812 accommodate the pre-adult life stages of Ae. aegypti [17] . We normalize the spline to a 7813 maximum of 1.
7814
At the beginning of the simulation, each location is assigned a maximum capacity 7815 sampled from an exponential distribution with a fitted mean, 1/M peak (see Section S5). 7816 We multiply the sampled peak for a given location by the seasonal scaling series to 7817 obtain the daily capacities for that location. Adjacency among the approximately 480k locations is determined using a filtered 7825 Delaunay triangulation [19] . We preclude long distance movement by removing edges with a haversine length greater than 1 km. As a consequence of traveling along this 7827 network, mosquitoes will only travel short distances in densely populated areas and 7828 longer distance in sparser areas, which is consistent with an empirical study [20] . female Ae. aegypti (Fig. C) incidence. We can maintain the correct expected dengue incidence, however, because we 7853 are fitting the number of biting mosquitoes. In this example, the mosquito population 7854 size parameter could increase to maintain a realistic force of infection.
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S4 Vaccination
7856
The effectiveness of vaccination strategies is assessed by contrasting the forecasted 7857 dengue burden with and without vaccine deployment over a 20 year period (see Time) 7858 corresponding to 2014-2033. We assume the vaccine gives partial, i.e., leaky, protection, 7859 and that vaccination does not affect infectiousness when breakthrough infections occur. 7860 All vaccinations occur on day 100 of the Julian calendar, which approximately 7861 corresponds to the epidemic nadir (see Fig. A 
Vaccinees retain perfect protective immunity against serotypes they were previously 7874 infected with. Among individuals with an infection history ("primed") who are 7875 challenged with a novel serotype, the modeled vaccine is highly effective against 
7889
Allowing coverage to vary while keeping the number of vaccinations fixed makes it 7890 easier to attribute the cause of effectiveness differences between strategies. In particular, 7891 it becomes possible to distinguish between the effects of better vaccine efficacy due to 7892 vaccinating older, antibody-positive individuals, versus administering more doses. Figure D . Waning vaccine models. problems [27, 28] .
7944
We do not know a priori the correlation between model parameters and simulated 7945 observed metrics, but we can use PLS to simultaneously orthonormalize both, into a Using the PLS regression corresponding to this reduced set of factors, we transform 7958 the empirical observed data, giving us empirical data in the reduced, orthogonal PLS A more precise description of our ABC-SMC algorithm is the following, based on an 7971 approach described in [26] , where N is the number of parameter combinations sampled, 7972 ρ is the fraction retained in the predictive prior/posterior, and n = ρ * N is the size of 7973 the predictive prior/posterior: 5. Set Θ (t) = best θ (t) , the best n samples, ranked by smallest distance. 
7994
B. Sample θ
7996
(e) Go to step 2.
7997
The weight function described in step 6(b)i favors parameter vectors that have 7998 relatively greater density in the prior distribution and lesser density in the most recent 7999 predictive prior, thus offsetting a sampling bias that would otherwise be introduced.
8000
The algorithm above differs from that in Beaumont (2010) biological explanation is that an introduced serotype is able to persist regionally until a 8041 threshold of herd immunity is reached, at which point dengue levels may decrease until 8042 another serotype is introduced or enough new susceptible people enter the population, 8043 via birth or immigration, for the first serotype to circulate again. Consistent with that 8044 interpretation-i.e. gaps are driven by herd immunity-we assume that the initial delay 8045 in appearance of a serotype is not a gap.
8046
We generate random sequences of alternating runs and gaps for each serotype by 8047 sampling from geometric distributions (i.e. year ranges of {1, 2, 3, . . . } with probabilities 8048 of {p,
Runs or gaps of length 0 do not occur. We use eight 8049 separate distributions: for runs and gaps, and for each of the four serotypes. We fit the 8050 distribution parameters p run , the probability that a run will end in a given year, and 8051 p gap , the probability that a gap will end, separately for each serotype using ABC-SMC. combinations, and keep the best 1% for the predictive priors and posterior.
8069
Fitting these parameters at the same time as the others might improve the dengue 8070 introduction match to observations, since there is an interplay between introduced 8071 serotypes and which are observed at what time, as well as inter-serotype dynamics.
8072
However, it is not practical because of how much it would increase the complexity of 8073 parameter space, and how long it takes to run the epidemic simulation once.
8074
Furthermore, the data available from the fitting period may not be particularly 8075 applicable to the past and forecast introduction series, given that these may be largely 8076 driven by external phenomena that are insufficiently reflected in the fitting period, so a 8077 more detailed approach is unlikely to improve forecasts.
8078
The actual observed, simulated observed, and distribution means are reported in E. Table E . Mean duration (years) of presence (runs) and absence (gaps) for each serotype. Simulated observed means were generated using the distribution means and then censored as the observed data were censored.
S5.4: Epidemic Model Parameter Estimation
The remaining model parameters 8080 were estimated using the ABC-SMC procedure described above to identify parameter 8081 combinations that produce dynamics similar to the observed data. For "similarity", we 8082 consider the following metrics: 
The mean, quartiles, standard deviation, and skewness have the conventional 8096 definitions. A median crossing is defined as a sequential pair of years with one year 8097 above and one below the whole series median, and the median crossing rate is the 8098 number of median crossings per total years considered minus one.
8099
Only limited serosurvey data are available: school children aged 8-14 in two groups, 8100 both within the municipality of Mérida, were tested in 1987, and were found to have 8101 seroprevalences of 56.3% and 63.7% [29] . We do not know how representative these 8102 samples were of the population of all 8-14 year-olds in Mérida, but they are nonetheless 8103 valuable in identifying the infection:reported case ratio. We assume an empirical 8104 seroprevalence of 60% for 8-14 year-olds in Mérida in 1987. When the simulator reaches 8105 April 9, 1987, we tally the seroprevalence for that subgroup of the Yucatán population 8106 as one of the metrics.
8107
The parameters fitted to the metrics are: Priors for these parameters are described in Table D .
8116
We use AbcSmc to fit these parameters. We ran AbcSmc for a total of 14 SMC sets, 8117 with a sample size of 10,000 parameter combinations for each set. To reduce the previously (see Section S2). The last 7 SMC sets used the full Yucatán population. The 8124 metrics we use are calculated on a per capita basis, so the interpretation of the metrics 8125 is insensitive to the size of the modeled population, but the size and spatial structure of 8126 the population (e.g., one large city versus that city and the surrounding towns and rural 8127 areas) may affect epidemic dynamics. Using a smaller population initially allowed us to 8128 focus in on promising regions of parameter space with faster-running simulations, which 8129 we then explored more thoroughly with the full population.
8130
We observed during the Yucatán SMC sets that the predictive priors were 8131 fluctuating noisily rather than converging: see, for example, the introduction rate λ E in 8132 Fig. E . This is may be due to inadequate sample size; however, sampling substantially 8133 more than 10,000 parameter combinations per set would be prohibitive, as each recalculate EIPs using the previously described approach, but with the daily T eff s 8156 instead.
8157
In general, we expect dengue incidence to increase with warmer climate. Because we 8158 assume that EIP decreases with increasing temperature, the likelihood that an infected 8159 mosquito will spread dengue before dying increases in turn. Indeed, when long-term 8160 warming is included in the model, we see that dengue incidence increases in both 8161 baseline and intervention scenarios (Fig. G) 
8189
Cumulative V eff is computed similarly, but from the start of the intervention up the 8190 relevant year, rather than annually.
8191
Annual V eff shows short-term vaccination scenario performance over moving one-year 8192 windows of an intervention, which corresponds to thinking about annual snapshots of 8193 the program. This is the during-an-outbreak view: for example, what the general 8194 populace or officials in a region undertaking a vaccine program might consider their 8195 outcomes compared to neighboring regions without vaccination. For effective programs, 8196 they will see lower disease burden in most years. However, in some particular year, an 8197 outbreak might occur in the region with vaccination and not in a non-vaccinating 8198 neighboring area, simply due to the stochastic nature of introduction of the pathogen, 8199 disease spread, and (particularly for dengue) manifestation of disease after infection. In 8200 the long view, for an effective intervention, these relatively bad years should be fewer 8201 and outweighed by the benefit in most years, so it is also useful to consider cumulative 8202 V eff .
8203
When aggregating over many simulated samples of these perspective, robustness is 8204 an important consideration in choice of statistic (e.g. mean versus median effectiveness), 8205 since the distribution of V eff can be highly skewed: it has an upper bound of 1 (at most, 8206 all cases can be avoided), is typically between 0 and 1 (i.e. the intervention is effective), 8207 but can go to negative infinity (i.e. when comparing any number of cases in an 8208 intervention to 0 cases in the baseline). It can also produce large negative V eff by chance 8209 when case counts are generally low, or (in the case of annual effectiveness) when an 8210 intervention postpones-but does not prevent-an epidemic from one year into another. 8211 Even though the resulting epidemic may be smaller, it may be compared to a small 
8216
The net result of these concerns is that mean V eff is not a robust statistic. If we 8217 calculated V eff on mean cases (instead of using the cases from each sample and then non-vaccinating, neighboring region reporting no cases when we reported five is not a 8223 huge public health failure). However, it does not properly account for large, negative 8224 annual V eff values associated with delayed epidemics in an intervention scenario when 8225 the baseline merely had its large epidemic earlier.
8226
Median and quantile V eff values, however, are robust, because they are not sensitive 8227 to the skewness of the V eff distribution. The sensitivity to negative V eff also tends to be 8228 eliminated when considering cumulative V eff s, since the synchronization of annual 8229 epidemics between scenarios becomes irrelevant: only total relative case counts for the 8230 considered years matters. Similarly, small outbreak years (and their potential for 8231 unimportant, yet large negative V eff ) are aggregated with large epidemic years, thus 8232 tending to make even net negative V eff small unless the intervention actually harms the 8233 population. This corresponds to our intuition about how good (or bad) an intervention 8234 is. This robustness is also why forecasted cumulative V eff has decreasing uncertainty: 8235 including more years means more time for the trend to emerge above inter-annual 8236 variation. Annual VE 95% (lightest) and 68% (darker) prediction intervals, and medians (solid line) for interventions with a durable vaccine. The panels are faceted by routine age of vaccination (rows) and routine versus routine and catchup campaigns (columns). Color is replicated from main text figures. Note that the lower forecast bound (2.5%) for the annual view is always negative, though it trends slowly upward (left out of frame), similar to the low bound (16%) for routine only strategies. For strategies with catchup campaigns, however, the resulting annual VE becomes less certain as the large initial coverage of seropositive vaccinees declines due to mortality.
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Figure K. Cumulative VE 95% (lightest) and 68% (darker) prediction intervals, and medians (solid line) for interventions with a durable vaccine. The panels are faceted by routine age of vaccination (rows) and routine versus routine and catchup campaigns (columns). Color is replicated from main text figures.
Figure L. Annual VE 95% (lightest) and 68% (darker) prediction intervals, and medians (solid line) for interventions with a waning vaccine and no booster vaccination campaigns. Routine age of vaccination is 9 years old. The panels are faceted by routine versus routine and catchup campaigns (rows) and waning half-life (columns). Color is replicated from main text figures. As noted in main text, a waning vaccine leads to limited VE, and when combined with a catchup campaign, leads to an expected temporary negative VE, which is not seen in any other scenario. 
